Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies
- PMID: 2182967
Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies
Abstract
The envelope of human immunodeficiency virus (HIV) is an essential building block of the virus and it plays a major role in its life-cycle, particularly during the early stages of infection. It very likely determines, at least in part, the host range and tissue specificity of HIV, participates in pathogenic processes mediated by the virus and can itself be immunosuppressive. Because of its strategic location on the outer surface of the virion and the infected cell, it also represents an optimal (although not the only) target for immune attack and thus a prime candidate for development of vaccine and therapeutic strategies. Efforts to better understand its structural, functional and antigenic properties will thus be well worthwhile. Some of its principal features are reviewed herein and its role in vaccine strategies is discussed.
Similar articles
-
Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.Behring Inst Mitt. 1994 Dec;(95):23-34. Behring Inst Mitt. 1994. PMID: 7755506 Review.
-
Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.Virology. 1993 Feb;192(2):447-57. doi: 10.1006/viro.1993.1060. Virology. 1993. PMID: 8421893
-
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).Cancer Res. 1985 Sep;45(9 Suppl):4694s-4699s. Cancer Res. 1985. PMID: 2410115 Review.
-
Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.J Infect Dis. 2000 Nov;182(5):1357-64. doi: 10.1086/315860. Epub 2000 Oct 9. J Infect Dis. 2000. PMID: 11023459 Clinical Trial.
-
Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development.Int Rev Immunol. 2004 Sep-Dec;23(5-6):423-36. doi: 10.1080/08830180490432802. Int Rev Immunol. 2004. PMID: 15370274 Review.
Cited by
-
Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.J Clin Microbiol. 1994 Jun;32(6):1449-56. doi: 10.1128/jcm.32.6.1449-1456.1994. J Clin Microbiol. 1994. PMID: 8077388 Free PMC article.
-
A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.Protein Sci. 1992 Nov;1(11):1454-64. doi: 10.1002/pro.5560011107. Protein Sci. 1992. PMID: 1303764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical